USPTO serial 79283542
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $975
CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)
JP
Other trademarks owned by CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)
CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)
JP
Other trademarks owned by CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)
CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)
JP
Other trademarks owned by CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lamara Parnell
Lamara Parnell Procopio, Cory, Hargreaves & Savitch LLP525 B Street, Suite 2200San Diego, CA 92101United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for human use to enhance efficiency of soluble antigen elimination from plasma, namely, pharmaceutical antibodies or its fragments or its derivatives, cells and genes that produce antibodies, fragments of antibodies or derivatives of antibodies for medical and pharmaceutical use | ACTIVE | — |
| 042 | Pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals | ACTIVE | — |
| 045 | Granting of licenses to others for the use of industrial property rights and copyrights | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Nov 3, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 21, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 17, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 17, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 3, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 3, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 18, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 18, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 29, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 13, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 29, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 29, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 29, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 29, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 22, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jun 17, 2020 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Jun 15, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 15, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 15, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jun 12, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jun 5, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 4, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 4, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 4, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 4, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 29, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 2, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 2, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 24, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 23, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 22, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 20, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 20, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |